The Quadra Allure MP™ CRT-P brings MultiPoint™ Pacing, an exclusive Abbott technology, to cardiac resynchronization therapy pacemakers (CRT-Ps).
MultiPoint Pacing technology is designed to deliver multiple independent left ventricular (LV) pacing pulses from a single quadripolar lead to provide you with CRT options to change:
Using the Quadra Allure MP CRT-P with Quartet™ quadripolar LV pacing lead, with its four pacing electrodes and 14 pacing vectors, provides more options and greater control in CRT response.
The recent IDE study1 post-hoc subanalysis (n = 199) showed that wider cathode spacing and near-simultaneous intraventricular timing delays provide best MPP technology response at 87 percent and “super-response” at 54 percent (52 patients).1
See details of the U.S. IDE study and other clinical support for MultiPoint Pacing.
This evidence builds on our quadripolar standard of care, which has offered you more options to pace at the preferred LV site, resulting in:
The Quadra Allure MP CRT-P offers Auto VectSelect Quartet™ Test that:
Pacing at the tissue site of latest activation improves:
Quadra Allure MP CRT-P helps you better manage your patients’ heart failure with intuitive programming options and timely access to their vital heart failure diagnostic data through radio frequency (RF) monitoring, providing:
The Quadra Allure MP™ CRT-P is one of our heart failure management therapies. Our vision is to transform the treatment of heart failure by designing technology that delivers excellent clinical outcomes and improves workflow and efficiency. Read more about our approach to heart failure management.